MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Penumbra EV 2011-2026 | PEN
EV Jährlich Penumbra
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 B | 10.3 B | 10.2 B | 8.38 B | 10.3 B | 6.3 B | 4.9 B | 3.37 B | 2.19 B | 525 M | 144 M | 75.1 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.5 B | 75.1 M | 5.6 B |
EV anderer Aktien in der Medizinische Geräte
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
932 M | $ 33.23 | 1.9 % | $ 1.47 B |  USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
994 M | $ 7.08 | 2.98 % | $ 508 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.75 | -1.83 % | $ 130 M | USA |
 |
Alphatec Holdings
ATEC
|
1.41 B | $ 13.37 | 2.06 % | $ 1.91 B | USA |
 |
EDAP TMS S.A.
EDAP
|
252 M | $ 4.7 | -1.44 % | $ 175 M |  France |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
170 M | $ 24.35 | 4.46 % | $ 206 M | USA |
 |
Bio-Rad Laboratories
BIO
|
10.1 B | $ 253.63 | -13.27 % | $ 7.16 B | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
3.81 B | $ 36.37 | -3.05 % | $ 5.42 K | USA |
 |
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
3.26 B | $ 41.78 | 0.26 % | $ 1.29 B | USA |
 |
Boston Scientific Corporation
BSX
|
155 B | $ 74.89 | 1.04 % | $ 110 B | USA |
 |
Abbott Laboratories
ABT
|
228 B | $ 112.43 | 0.86 % | $ 196 B | USA |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Delcath Systems
DCTH
|
350 M | $ 9.26 | 1.48 % | $ 264 M | USA |
 |
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
459 M | $ 13.4 | 2.76 % | $ 362 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
Inogen
INGN
|
203 M | $ 5.8 | 0.17 % | $ 137 M | USA |
 |
InMode Ltd.
INMD
|
3.99 B | $ 14.41 | 0.79 % | $ 1.14 B | Israel |
 |
IRadimed Corporation
IRMD
|
629 M | $ 100.64 | 0.8 % | $ 1.28 B | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
347 M | $ 1.49 | 4.58 % | $ 58.3 M | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
5.99 B | $ 85.98 | 0.73 % | $ 2.89 B | USA |
 |
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
91.5 M | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
Insulet Corporation
PODD
|
17.5 B | $ 244.13 | 1.37 % | $ 17.1 B | USA |
 |
Profound Medical Corp.
PROF
|
-13.5 M | $ 6.56 | 5.3 % | $ 180 M | Canada |
 |
Globus Medical
GMED
|
11.7 B | $ 88.42 | 1.38 % | $ 12 B | USA |
 |
Sintx Technologies
SINT
|
3.44 M | $ 3.0 | 10.29 % | $ 11.2 M | USA |